MedeAnalytics Promotes the Importance of Early Breast Cancer Detection

October 1, 2019/MedeAnalytics

In October, MedeAnalytics is recognizing Breast Cancer Awareness Month, a worldwide campaign to increase awareness, education and research about breast health and the importance of early detection. Breast cancer is the second most common kind of cancer in women, and one in eight women will get breast cancer in their life time. Through annual screenings like mammograms, women can survive breast cancer when it’s found and treated early.

Here’s how MedeAnalytics will recognize Breast Cancer Awareness Month:

Our associates will be participating as a team, Mede Pirates of The Cure-Ribbean, in the Race for the Cure in Dallas on Saturday, October 26 and remote employees will be joining their local races.
MedeAnalytics has partnered with Susan G. Komen to present a collaborative Lunch & Learn educational event hosted by Susan G. Komen ambassador Natasha Mmeje. MedeAnalytics’ employees will learn about the latest in breast cancer research and treatment resources.
Wear Pink Wednesdays will be acknowledged throughout October to drive awareness
Employees can share their personal stories of their loved ones and friends to show support on our internal message board

Join us as we participate in promoting this important message of hope and support.

Posted in MedeAnalytics

MedeAnalytics

MedeAnalytics is a leader in healthcare analytics, providing innovative solutions that enable measurable impact for healthcare payers and providers. With the most advanced data orchestration in healthcare, payers and providers count on us to deliver actionable insights that improve financial, operational, and clinical outcomes. To date, we’ve helped uncover millions of dollars in savings annually.